跳至主要内容
临床试验/NCT01172132
NCT01172132已完成不适用

Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 1,011 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,011
试验地点
1
主要终点
Survival status at one year

研究概览

简要总结

The purpose of this study is to determine:

  • Condition of intensive care unit (ICU) admission in patients with haematological malignancies.
  • ICU hospital and up to one year mortality.
  • Assessment of post ICU burden and health related quality at 90-d and 1 year.

详细描述

  1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy
  2. Evaluate the health related quality of life of intensive care survivors(SF36)
  3. Impact of intensive care on families burden (HADS, IES).
  4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making.
  5. Establish the relevance of antifungal treatments.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hematological malignancies
  • hospitalization in ICU
  • age >= 18 years

排除标准

  • Patients who have already participated to TRIAL-OH

结局指标

主要结局

Survival status at one year

时间窗: 1 year

survival status (alive or death) at one year

次要结局

  • Survival status(day 90)
  • ICU mortality(1 week (estimated mean time until ICU discharge))
  • Hospital mortality(3 weeks (estimated mean time until Hospital discharge))
  • Health related quality of life of patients and their relatives(day 90 and 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验